Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact

Review

  • 161 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next →
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs
Herbert Y. Meltzer, Bryan L. Roth
Herbert Y. Meltzer, Bryan L. Roth
Published December 2, 2013
Citation Information: J Clin Invest. 2013;123(12):4986-4991. https://doi.org/10.1172/JCI70678.
View: Text | PDF

Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype–targeted drugs

  • Text
  • PDF
Abstract

Serotonin (5-hydroxytryptamine, or 5-HT) receptors mediate a plethora of physiological phenomena in the brain and the periphery. Additionally, serotonergic dysfunction has been implicated in nearly every neuropsychiatric disorder. The effects of serotonin are mediated by fourteen GPCRs. Both the therapeutic actions and side effects of commonly prescribed drugs are frequently due to nonspecific actions on various 5-HT receptor subtypes. For more than 20 years, the search for clinically efficacious drugs that selectively target 5-HT receptor subtypes has been only occasionally successful. This review provides an overview of 5-HT receptor pharmacology and discusses two recent 5-HT receptor subtype–selective drugs, lorcaserin and pimavanserin, which target the 5HT2C and 5HT2A receptors and provide new treatments for obesity and Parkinson’s disease psychosis, respectively.

Authors

Herbert Y. Meltzer, Bryan L. Roth

×

Deep brain stimulation (DBS) at the interface of neurology and psychiatry
Nolan R. Williams, Michael S. Okun
Nolan R. Williams, Michael S. Okun
Published November 1, 2013
Citation Information: J Clin Invest. 2013;123(11):4546-4556. https://doi.org/10.1172/JCI68341.
View: Text | PDF

Deep brain stimulation (DBS) at the interface of neurology and psychiatry

  • Text
  • PDF
Abstract

Deep brain stimulation (DBS) is an emerging interventional therapy for well-screened patients with specific treatment-resistant neuropsychiatric diseases. Some neuropsychiatric conditions, such as Parkinson disease, have available and reasonable guideline and efficacy data, while other conditions, such as major depressive disorder and Tourette syndrome, have more limited, but promising results. This review summarizes both the efficacy and the neuroanatomical targets for DBS in four common neuropsychiatric conditions: Parkinson disease, Tourette syndrome, major depressive disorder, and obsessive-compulsive disorder. Based on emerging new research, we summarize novel approaches to optimization of stimulation for each neuropsychiatric disease and we review the potential positive and negative effects that may be observed following DBS. Finally, we summarize the likely future innovations in the field of electrical neural-network modulation.

Authors

Nolan R. Williams, Michael S. Okun

×

The genomics of schizophrenia: update and implications
Paola Giusti-Rodríguez, Patrick F. Sullivan
Paola Giusti-Rodríguez, Patrick F. Sullivan
Published November 1, 2013
Citation Information: J Clin Invest. 2013;123(11):4557-4563. https://doi.org/10.1172/JCI66031.
View: Text | PDF

The genomics of schizophrenia: update and implications

  • Text
  • PDF
Abstract

Schizophrenia is strongly familial yet rarely (if ever) exhibits classical Mendelian inheritance patterns. The advent of large-scale genotyping and sequencing projects has yielded large data sets with higher statistical power in an effort to uncover new associations with schizophrenia. Here, we review the challenges in dissecting the genetics of schizophrenia and provide an update of the current understanding of the underlying genomics. We discuss the breadth of susceptibility alleles, including those that may occur with low frequency and high disease risk, such as the 22q11.2 hemideletion, as well as alleles that may occur with greater frequency but convey a lower risk of schizophrenia, such as variants in genes encoding subunits of the voltage-gated L-type calcium channel. Finally, we provide an overview of the clinical implications for the diagnosis and treatment of schizophrenia based on progress in understanding the underlying genetic basis.

Authors

Paola Giusti-Rodríguez, Patrick F. Sullivan

×

Emerging concepts in immunity to hepatitis C virus infection
Hugo R. Rosen
Hugo R. Rosen
Published October 1, 2013
Citation Information: J Clin Invest. 2013;123(10):4121-4130. https://doi.org/10.1172/JCI67714.
View: Text | PDF

Emerging concepts in immunity to hepatitis C virus infection

  • Text
  • PDF
Abstract

Since the discovery of hepatitis C virus (HCV) by molecular cloning almost a quarter of a century ago, unprecedented at the time because the virus had never been grown in cell culture or detected serologically, there have been impressive strides in many facets of our understanding of the natural history of the disease, the viral life cycle, the pathogenesis, and antiviral therapy. It is apparent that the virus has developed multiple strategies to evade immune surveillance and eradication. This Review covers what we currently understand of the temporal and spatial immunological changes within the human innate and adaptive host immune responses that ultimately determine the outcomes of HCV infection.

Authors

Hugo R. Rosen

×

Signaling at neuro/immune synapses
Michael L. Dustin
Michael L. Dustin
Published April 2, 2012
Citation Information: J Clin Invest. 2012;122(4):1149-1155. https://doi.org/10.1172/JCI58705.
View: Text | PDF

Signaling at neuro/immune synapses

  • Text
  • PDF
Abstract

Immunological and neural synapses share properties such as the synaptic cleft, adhesion molecules, stability, and polarity. However, the mismatch in scale has limited the utility of these comparisons. The discovery of phosphatase micro-exclusion from signaling elements in immunological synapses and innate phagocytic synapses define a common functional unit at a common sub-micron scale across synapse types. Bundling of information from multiple antigen receptor microclusters by an immunological synapse has parallels to bundling of multiple synaptic inputs into a single axonal output by neurons, allowing integration and coincidence detection. Bonafide neuroimmune synapses control the inflammatory reflex. A better understanding of the shared mechanisms between immunological and neural synapses could aid in the development of new therapeutic modalities for immunological, neurological, and neuroimmunological disorders alike.

Authors

Michael L. Dustin

×

The adaptive immune system in diseases of the central nervous system
David C. Wraith, Lindsay B. Nicholson
David C. Wraith, Lindsay B. Nicholson
Published April 2, 2012
Citation Information: J Clin Invest. 2012;122(4):1172-1179. https://doi.org/10.1172/JCI58648.
View: Text | PDF

The adaptive immune system in diseases of the central nervous system

  • Text
  • PDF
Abstract

Tissues of the CNS, such as the brain, optic nerves, and spinal cord, may be affected by a range of insults including genetic, autoimmune, infectious, or neurodegenerative diseases and cancer. The immune system is involved in the pathogenesis of many of these, either by causing tissue damage or alternatively by responding to disease and contributing to repair. It is clearly vital that cells of the immune system patrol the CNS and protect against infection. However, in contrast to other tissues, damage caused by immune pathology in the CNS can be irreparable. The nervous and immune systems have, therefore, coevolved to permit effective immune surveillance while limiting immune pathology. Here we will consider aspects of adaptive immunity in the CNS and the retina, both in the context of protection from infection as well as cancer and autoimmunity, while focusing on immune responses that compromise health and lead to significant morbidity.

Authors

David C. Wraith, Lindsay B. Nicholson

×

Lessons learned at the intersection of immunology and neuroscience
Lawrence Steinman
Lawrence Steinman
Published April 2, 2012
Citation Information: J Clin Invest. 2012;122(4):1146-1148. https://doi.org/10.1172/JCI63493.
View: Text | PDF

Lessons learned at the intersection of immunology and neuroscience

  • Text
  • PDF
Abstract

Neurobiologists and immunologists study concepts often signified with identical terminology. Scientists in both fields study a structure known as the synapse, and each group analyzes a subject called memory. Is this a quirk of human language, or are there real similarities between these two physiological systems? Not only are the linguistic concepts expressed in the words “synapse” and “memory” shared between the fields, but the actual molecules of physiologic importance in one system play parallel roles in the other: complement, the major histocompatibility molecules, and even “neuro”-transmitters all have major impacts on health and on disease in both the brain and the immune system. Not only are the same molecules found in diverse roles in each system, but we have learned that there is real “hard-wired” crosstalk between nerves and lymphoid organs. This issue of the JCI highlights some of the lessons learned from experts who are working at this scintillating intersection between immunology and neuroscience.

Authors

Lawrence Steinman

×

Innate immunity in the central nervous system
Richard M. Ransohoff, Melissa A. Brown
Richard M. Ransohoff, Melissa A. Brown
Published April 2, 2012
Citation Information: J Clin Invest. 2012;122(4):1164-1171. https://doi.org/10.1172/JCI58644.
View: Text | PDF

Innate immunity in the central nervous system

  • Text
  • PDF
Abstract

Immune responses in the CNS are common, despite its perception as a site of immune privilege. These responses can be mediated by resident microglia and astrocytes, which are innate immune cells without direct counterparts in the periphery. Furthermore, CNS immune reactions often take place in virtual isolation from the innate/adaptive immune interplay that characterizes peripheral immunity. However, microglia and astrocytes also engage in significant cross-talk with CNS-infiltrating T cells and other components of the innate immune system. Here we review the cellular and molecular basis of innate immunity in the CNS and discuss what is known about how outcomes of these interactions can lead to resolution of infection, neurodegeneration, or neural repair depending on the context.

Authors

Richard M. Ransohoff, Melissa A. Brown

×

Multiple sclerosis
Alyssa Nylander, David A. Hafler
Alyssa Nylander, David A. Hafler
Published April 2, 2012
Citation Information: J Clin Invest. 2012;122(4):1180-1188. https://doi.org/10.1172/JCI58649.
View: Text | PDF

Multiple sclerosis

  • Text
  • PDF
Abstract

Multiple sclerosis (MS) is a multifocal demyelinating disease with progressive neurodegeneration caused by an autoimmune response to self-antigens in a genetically susceptible individual. While the formation and persistence of meningeal lymphoid follicles suggest persistence of antigens to drive the continuing inflammatory and humoral response, the identity of an antigen or infectious agent leading to the oligoclonal expansion of B and T cells is unknown. In this review we examine new paradigms for understanding the immunopathology of MS, present recent data defining the common genetic variants underlying disease susceptibility, and explore how improved understanding of immune pathway disruption can inform MS prognosis and treatment decisions.

Authors

Alyssa Nylander, David A. Hafler

×

The immunology of neurodegeneration
Eva Czirr, Tony Wyss-Coray
Eva Czirr, Tony Wyss-Coray
Published April 2, 2012
Citation Information: J Clin Invest. 2012;122(4):1156-1163. https://doi.org/10.1172/JCI58656.
View: Text | PDF

The immunology of neurodegeneration

  • Text
  • PDF
Abstract

While immune responses in neurodegeneration were regarded as little more than a curiosity a decade ago, they are now increasingly moving toward center stage. Factors driving this movement include the recognition that most of the relevant immune molecules are produced within the brain, that microglia are proficient immune cells shaping neuronal circuitry and fate, and that systemic immune responses affect brain function. We will review this complex field from the perspective of neurons, extra-neuronal brain cells, and the systemic environment and highlight the possibility that cell intrinsic innate immune molecules in neurons may function in neurodegenerative processes.

Authors

Eva Czirr, Tony Wyss-Coray

×
  • ← Previous
  • 1
  • 2
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts